Andrew Baschnagel

Summary

Affiliation: University at Buffalo
Country: USA

Publications

  1. pmc Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
    Prajnan Das
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    Radiat Oncol 1:41. 2006
  2. pmc Neuropsychological testing and biomarkers in the management of brain metastases
    Andrew Baschnagel
    Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10 CRC, Room B2 3561, Bethesda, Maryland, 20892, USA
    Radiat Oncol 3:26. 2008
  3. pmc Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
    Andrew Baschnagel
    Radiation Oncology Branch, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    Mol Cancer Ther 8:1589-95. 2009

Collaborators

Detail Information

Publications3

  1. pmc Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
    Prajnan Das
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    Radiat Oncol 1:41. 2006
    ..Therefore, capecitabine and concurrent radiotherapy to the upper abdomen appears to be well tolerated. Capecitabine may serve as an alternative to bolus or infusional 5-FU during chemoradiation for upper gastrointestinal malignancies...
  2. pmc Neuropsychological testing and biomarkers in the management of brain metastases
    Andrew Baschnagel
    Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10 CRC, Room B2 3561, Bethesda, Maryland, 20892, USA
    Radiat Oncol 3:26. 2008
    ....
  3. pmc Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
    Andrew Baschnagel
    Radiation Oncology Branch, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    Mol Cancer Ther 8:1589-95. 2009
    ..There was a greater than additive improvement in survival in our intracranial model. Combining vorinostat with radiation may be a potential treatment option for patients with breast cancer who develop brain metastases...